Ipsen R&D chief stepping down

Ipsen Group (Euronext:IPN; Pink:IPSEY) said EVP of R&D and CSO Claude Bertrand will leave to join another company, effective Jan. 2, 2017. The company's SVP of global drug development, Alexandre Lebeaut, will lead Ipsen's R&D division until it names a permanent successor. Lebeaut joined the company in 2012...